- Home
- APLM vs STSS Comparison
APLM vs STSS Comparison
Compare APLM & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- STSS
- Stock Information
- Founded
- APLM 2016
- STSS 2017
- Country
- APLM United States
- STSS United States
- Employees
- APLM N/A
- STSS N/A
- Industry
- APLM Blank Checks
- STSS Medical/Dental Instruments
- Sector
- APLM Finance
- STSS Health Care
- Exchange
- APLM Nasdaq
- STSS Nasdaq
- Market Cap
- APLM 6.1M
- STSS 5.1M
- IPO Year
- APLM N/A
- STSS 2022
- Fundamental
- Price
- APLM $18.43
- STSS $8.09
- Analyst Decision
- APLM
- STSS
- Analyst Count
- APLM 0
- STSS 0
- Target Price
- APLM N/A
- STSS N/A
- AVG Volume (30 Days)
- APLM 89.6K
- STSS 3.6M
- Earning Date
- APLM 09-30-2025
- STSS 11-13-2025
- Dividend Yield
- APLM N/A
- STSS N/A
- EPS Growth
- APLM N/A
- STSS N/A
- EPS
- APLM N/A
- STSS N/A
- Revenue
- APLM $198,000.00
- STSS $222,722.00
- Revenue This Year
- APLM $415.15
- STSS N/A
- Revenue Next Year
- APLM N/A
- STSS N/A
- P/E Ratio
- APLM N/A
- STSS N/A
- Revenue Growth
- APLM N/A
- STSS N/A
- 52 Week Low
- APLM $3.66
- STSS $3.36
- 52 Week High
- APLM $35.98
- STSS $1,617.00
- Technical
- Relative Strength Index (RSI)
- APLM 90.29
- STSS 45.75
- Support Level
- APLM $3.66
- STSS $7.90
- Resistance Level
- APLM $6.37
- STSS $10.93
- Average True Range (ATR)
- APLM 1.65
- STSS 1.74
- MACD
- APLM 1.20
- STSS -0.49
- Stochastic Oscillator
- APLM 85.30
- STSS 2.54
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.